In another study using a mouse model of NEC, enteral recombinant lactoferrin administration (6 g/L) prevented a NEC protocol induced decrease in Ki67 immunoreactivity, preserved beta-catenin immunoreactivity and restored LGR5 mRNA levels in the distal ileum [101]. The gene discussed is LTF; the disease is necrotizing enterocolitis.